Alvotech

Alvotech is a biotechnology company focused on the development, manufacture and commercialisation of biosimilar medicines. Founded in 2013 by Róbert Wessman and headquartered in Reykjavik, Iceland, the company operates in Europe and the United States and works across the biotechnology, pharmaceuticals, healthcare and biologics sectors.

The company's pipeline comprises approximately 12 biosimilar candidates aimed at therapeutic areas including immunology, oncology and ophthalmology. Alvotech pursues a vertically integrated production model that spans cell line creation, process development, biologics manufacturing and fill and finish, a structure the company describes as emphasising scale, speed and control in order to deliver high-quality, cost-competitive products. Commercial partnerships are in place with Teva Pharmaceuticals, Dr. Reddy's and Advanz Pharma.

Alvotech states a mission of broadening access to affordable biologic medicines and improving the sustainability of the global healthcare ecosystem. The company operates from Iceland in order to draw on the country's renewable energy resources, and reports maintaining environmental, social and governance (ESG) standards across its operations.